'Preimplantation Genetic Diagnosis 2018: Current Practice and Beyond', 9-10 November 2018
Page URL: https://www.bionews.org.uk/page_93712

Event Review: 1000 Genomes Project Community Meeting

30 July 2012
Appeared in BioNews 667

The 1000 Genomes Project, an initiative to sequence the genetic code of 2,500 people across five continents, has now successfully sequenced over 1,000 people's genomes.

On 12 and 13 July, the project's team met with the wider genomics community at the University of Michigan, Ann Arbor, USA, to discuss the progression, applications and challenges of the project, as well as future directions for community sequencing.

This year's meeting was an enjoyable and engaging event, providing an overview of the scientific advances allowed by the project, including analysis, community resources and research applications. There was also a useful discussion of what to prioritise in terms of future requirements and next steps.

Talks by a host of leading geneticists and statisticians included Professors Gonçalo Abecasis, who organised the meeting, Richard Durbin (Wellcome Trust Sanger Institute), Gil McVean (University of Oxford) and Nancy Cox (University of Chicago).

The 1000 Genomes Project offers an unprecedented opportunity to chart genetic variation between individuals. Because the data is being made freely available, ideas can be shared and numerous researchers have been instrumental in solving technical and analytical challenges. Despite not being completely finished, this resource has become indispensable as a reference panel of variants for genetic studies.

Professor Gonçalo Abecasis highlighted other important contributions of the project, notably the creation of a standardised data format to allow the results to be stored and shared more easily and the development of methods and tools for analysing this type of data.

He added that collaboration between three groups involved in the analysis, from the Broad Institute in Boston, the University of Michigan and Wellcome Trust Sanger Institute, Cambridge, resulted in an overall reduction in error rates of 40 percent.

The meeting covered various methods used for sequence analysis, their applications and potential future uses. One of the remaining challenges discussed was that the human genome reference, which is used to align genetic sequences to their correct position in the genome, is only 95 percent complete. This means that an individual's genetic code can't be completed using just this reference. Improvements are therefore needed to fill this gap in the genetic sequence.

Another challenge is to accurately assess complicated mutations – current techniques are very good at identifying single changes in the letters making up the genetic code, but not as efficient for more complex alterations.

Further discussions involved using large scale sequencing studies for understanding the genetic basis of human diseases, including schizophrenia. Others talked about using data from the project to help genetic studies of conditions such as Crohn's disease and type II diabetes.

Professor Cisca Wijmenga talked about the influence of the 1000 Genomes on the Genomes of the Netherlands project, in terms of development of techniques and tools. However, she noted that 40 percent of the genetic variations identified in this project were not present in the 1000 Genomes' data, bringing home the importance of sequencing additional populations.

The meeting closed with a discussion of the future of large scale sequencing studies, which allowed the audience to contribute their own thoughts and what they think should take priority. The wish lists of many speakers were nicely summarised by Professor Durbin as: sequencing more individuals from different ancestry; achieving greater accuracy and more complete genomes by improving analysis; and eventually sequencing more individuals more thoroughly to improve data quality.

He added that we now need ideas and vision, and new people who will take these challenges on.

The #1000genomes Twitter coverage of the meeting has been Storfied here, and more information on the 1000 Genomes Project is available here. The meeting was sponsored by Illumina, Complete Genomics and Roche.


SOURCES & REFERENCES
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
26 May 2015 - by Sandy Starr 
From February to April 2015, readers of BioNews were asked for their views on the 100,000 Genomes Project - a UK Government initiative which aims to sequence 100,000 whole genomes from NHS patients and their families. 775 of you responded to our poll...
10 December 2012 - by Purvi Shah 
An average person carries roughly 400 potentially damaging mutations in their DNA, say geneticists...
5 November 2012 - by Dr Nicola Davis 
Over 1,000 people from 14 countries have had their genomes mapped by scientists. The researchers say their study will help them examine genetic variations at the scale of national populations and further identification of the rare genetic variations related to many diseases...
20 February 2012 - by Dr Rosie Gilchrist 
Twenty completely inactive genes have been identified by scientist studying so called 'loss of function' mutations in the human genome...
28 June 2010 - by Dr Vivienne Raper 
The largest study of genetic differences between people to date - the 1,000 Genomes Project - has completed its pilot studies. The data is now freely available...
27 January 2008 - by Dr Jess Buxton 
An international project to read the entire genetic code of at least 1000 individuals will result in a comprehensive catalogue of human variation that will accelerate efforts to identify genetic factors involved in health and disease, scientists announced last week. The '1000 Genomes Project' will take...
9 October 2006 - by Antony Blackburn-Starza 
The X Prize Foundation is offering $10m to the first private team that is able to sequence 100 human genomes in just ten days. It would currently take months, at the cost of millions of dollars, to sequence an individual human genome. Francis Collins, director of the...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.